KENTA BIOTECH AG has a total of 36 patent applications. Its first patent ever was published in 2003. It filed its patents most often in EPO (European Patent Office), China and Republic of Korea. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are ONCOMED PHARM INC, HIMMLER GOTTFRIED and FUNDACIO PRIVADA INST CATALANA DE RECERCA I ESTUDIS AVANCATS.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 8 | |
#2 | China | 5 | |
#3 | Republic of Korea | 5 | |
#4 | WIPO (World Intellectual Property Organization) | 5 | |
#5 | Canada | 4 | |
#6 | Brazil | 3 | |
#7 | Israel | 2 | |
#8 | Mexico | 2 | |
#9 | India | 1 | |
#10 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Measuring microorganism processes | |
#5 | Unspecified technologies | |
#6 | Analysing materials | |
#7 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Rudolf Michael | 20 |
#2 | Koch Holger | 18 |
#3 | Horn Michael P | 8 |
#4 | Imboden Martin A | 8 |
#5 | Lang Alois B | 7 |
#6 | Emrich Thomas | 7 |
#7 | Zuercher Adrian | 5 |
#8 | Fas Stefanie | 5 |
#9 | Haake Markus | 3 |
#10 | Urwyler Simon | 3 |
Publication | Filing date | Title |
---|---|---|
EP2599496A1 | Novel targets of Acinetobacter baumannii | |
WO2010115606A1 | Human monoclonal antibody specific for lipopolysaccarides (lps) of serotype iats 01 of pseudomonas aeruginosa | |
EP2361989A1 | Assays and kits for serotyping Pseudomonas aeruginosa and oligonucleotide sequences useful in such methods and kits | |
EP2284193A1 | Human monoclonal antibody against S. aureus derived apha-toxin and its use in treating or preventing abscess formation | |
EP1690875A1 | Human monoclonal antibody specific for lipopolysaccharides (LPS) of the pseudomonas aeruginosa IATS O11 serotype | |
EP1479695A1 | Human monoclonal antibody specific for lipopolysaccharides (LPS) of serotype IATS O6 of Pseudomonas aeruginosa |